Beremagene Geperpavec: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Beremagene Geperpavec. Educational only — not medical advice.
Labeled uses
VYJUVEK is indicated for the treatment of wounds in adult and pediatric patients with dystrophic epidermolysis bullosa (DEB) with mutation(s) in the collagen type VII alpha 1 chain (COL7A1) gene.
Source: FDA labeling via NIH DailyMed (set fe207c8c…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.